|
|||||
|
-Versant- |
|||||
|
Versant Ventures
Offices: Menlo Park-Newport Beach, California
At Versant Ventures they work with early-stage companies to target the largest
market opportunities in the medical devices, healthcare services, healthcare
information technology and life sciences industries. They partner with creative
and experienced entrepreneurs to help them build successful companies poised
to transform existing markets or create brand new ones. They approach
each market category from an experienced perspective that comes from more
than 175 years of combined experience as entrepreneurs and senior management
executives. |
|||||
|
Vesalius Biocapital
Offices: Luxemburg, Germany
Vesalius Biocapital Partners manages a mid-size venture capital fund that
invests in young, early- and mid-stage European life sciences companies
creating innovative drugs, diagnostics and cutting-edge biomedical technologies.
They are building a diversified portfolio of companies with a balances risk
structure and with financial attractiveness translating into above average
returns on investments. |
|||||
| Viscogliosi
Bros (VB)
Offices: New York, New York
Viscogliosi Bros was the first venture capital/private equity and merchant
banking firm dedicated to the musculoskeletal/orthopedics sector of the
healthcare industry. The principals of VB have a combined total of more
than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. Since inception, VB has led or participated in more than 40 transactions
in the musculoskeletal/orthopedics industry. |
|||||
| Vivo
Ventures
Offices: Palo Alto, California
Vivo Ventures is a life-sciences focused venture capital firm formed in
1996 with approximately $200 MM under management. Vivo Ventures is currently
making investments from its fourth fund, Biotechnology Development Fund
IV, into promising biotechnology and life science companies. With over 90
years of scientific and operational expertise in biotechnology, Vivo makes
investment decisions for the Funds and helps its portfolio companies develop
corporate strategy, arrange licensing agreements and strategic alliances,
recruit key management personnel, and acquire new products and technology
to accelerate growth. |
|||||
|
-Water Street- |
|||||
| Water
Street Healthcare Partners
Offices: Chicago, Illinois
Water Street Healthcare Partners is a private equity firm with an outstanding
track record of building market leading healthcare companies. Their focus
is helping growth-oriented management teams identify and evaluate opportunities
to dramatically increase the value of their business. By leveraging their
deep industry knowledge and their extensive network of contacts, they help
managers accelerate growth and create companies of substantially greater
value. |
|||||
|
WFD
Ventures
Offices: New York, New York
WFD Ventures provides equity financing and industry expertise to medical
device and healthcare technology companies. The principals of WFD have extensive
experience commercializing medical technologies and seek partnerships with
entrepreneurs, doctors and scientists to improve medical outcomes and maximize
the financial potentials of their innovations. |
|||||
|
Windamere
Venture Partners
Offices: La Jolla, California
Since its inception in 1998, Windamere Venture Partners has supported more
than a dozen pharmaceutical, biotechnology, medical device, and other healthcare
companies from the very early stages. Their approach combines a specialized
investment focus with active management and long-term commitment to ensure
the highest rates-of-return for both entrepreneurs and investors. Windamere
leverages its substantial prior experience forming and financing new healthcare
ventures in order to transform new ideas and concepts into commercial success. |
|||||
|
-Yankee- |
|||||
|
Yankee Equity Solution
Offices: Cotuit, Massachusetts
Yankee Equity Solution (YES) manages the YES Medical Technology Fund, a
$50 million private equity vehicle that helps Massachusetts-based medical
technology companies, that have revenues and profits, to expand their commercialization
efforts. More specifically, the YES Medical Technology Fund provides growth
capital to medtech companies that have revenues of at least $10 million,
are profitable, and have the potential to be number-one or two in their
target market. |
|||||
|
-Ziegler- |
|||||
| Ziegler
(ZMEP)
Offices: Milwaukee, Wisconsin
Ziegler MediTechAdvisors is a limited partnership focusing on equity and
equity-like investments in emerging medical device technologies. ZMEP invests
globally drawing on the years of investing experience of its management
team. With over 50 years of experience in medical device development and
commercialization, the ZMEP management team has the ability to seek out
and partner with leading entrepreneurs in the medical device field. |
|||||